Efficacy of systemic cyclosporine A and amniotic membrane on rabbit conjunctival limbal allograft rejection

Cornea

Volumn 24, Issue 2, 2005, Pages 182-188

  Dios, Enrique ^a   Herreras, Jose M ^a   Mayo, Agustin ^a   Blanco, Gonzalo ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Amniotic membrane; Cyclosporine; Graft rejection; Rabbit limbal allografts

Indexed keywords

CYCLOSPORIN A;

ALLOGRAFT; AMNION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; LIMBAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

AMNION; ANIMALS; COMBINED MODALITY THERAPY; CONJUNCTIVA; CORNEAL DISEASES; CYCLOSPORINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; RABBITS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 14144250649     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000138831.57736.e0     Document Type: Article

References (64)

1. Cotsarelis G, Cheng SZ, Dong G, et al. Existence of slow cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on limbal stem cells. Cell. 1989;57:201-209.
2. Dua HS, Azuara-Blanco A. Limbal stem cells of the corneal epithelium. Surv Ophthalmol. 2000;44:415-425.
3. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96:709-722.
4. Kruse FE. Stem cells and corneal epithelial regeneration. Eye. 1994;8:170-183.
5. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64-k corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103:49-62.
6. Tseng SCG. Concept and application of limbal stem cells. Eye. 1989;3:141-149.
7. Zieske JD, Bukosuglu G, Yankauckas MA. Characterization of a potential marker of corneal epithelial stem cells. Invest Ophthalmol Vis Sci. 1992;33:143-152.
8. Akpek EK, Foster CS. Limbal stem-cell transplantation. Int Ophthalmol Clin. 1999;39:71-82.
9. Puangsricharern V, Tseng SCG. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102:1476-1485.
10. Thoft RA. Keratoepithelioplasty. Am J Ophthalmol. 1984;97:1.
11. Thoft RA. Conjunctival transplantation. Arch Ophthalmol. 1977;95:1425.
12. Avila M, España M, Moreno C, et al. Reconstruction of ocular surface with heterologous limbal epithelium and amniotic membrane in a rabbit model. Cornea. 2001;20:414-420.
13. Koizumi N, Inatomi T, Quantock AJ, et al. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea. 2000;19:65-71.
14. Tsai RJF, Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea. 1994;13:389-400.
15. Coster DJ, Aggarwal RK, Williams KA. Surgical management of ocular surface disorders using conjunctival and stem cell allografts. Br J Ophthalmol. 1995;79:977-982.
16. Tsubota K, Toda I, Saito H, et al. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology. 1995;102:1486-1496.
17. Williams KA, Brereton HM, Aggarwal R, et al. Use of DNA polymorphisms and the polymerase chain reaction to examine the survival of a human limbal stem cell allograft. Am J Ophthalmol. 1995;120:342-350.
18. Tan DT, Ficker LA, Buckley RJ. Limbal transplantation. Ophthalmology. 1996;103:29-36.
19. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
20. Croasdale CR, Schwartz GS, Malling JV, et al. Keratolimbal allograft: recommendations for tissue procurement and preparation by eye banks, and standard surgical technique. Cornea. 1999;18:52-58.
21. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 1999;83:414-419.
22. Rao SK, Rajagopal R, Sitalakshmi G, et al. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology. 1999;106:822-828.
23. Daya SM, Ilari L. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology. 2001;108:126-134.
24. Kwitko S, Marinho D, Barcaro S, et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology. 1995;102:1020-1025.
25. Theng JT, Tan DT. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns. Ophthalmic Surg Lasers. 1997;28:765-768.
26. Xu K, Wu Y, Zhou J, et al. Survival of rabbit limbal stem cell allografts after administration of cyclosporin A. Cornea. 1999;18:459-465.
27. Mills RAD, Coster DJ, Williams KA. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation. Invest Ophthalmol Vis Sci. 2002;43:647-655.
28. Swift GJ, Aggarwal RK, Davis GJ, et al. Survival of rabbit limbal stem cell allografts. Transplantation. 1996;62:568-574.
29. Daya SM, Bell RW, Habib NE, et al. Clinical and pathologic findings in human keratolimbal allograft rejection. Cornea. 2000;19:443-450.
30. Tseng SCG, Prabhasawat P, Barton K, et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
31. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology. 2003;110:125-130.
32. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology. 2002;109:1159-1166.
33. Lee S, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
34. Prabhasawat P, Barton K, Burkett G, et al. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology. 1997;104:974-985.
35. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol. 1997;115:1360-1367.
36. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82:235-240.
37. Shimazaki J, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology. 1997;104:2068-2076.
38. Kubo M, Sonoda Y, Muramatsu R, et al. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci. 2001;42:1539-1546.
39. Ueta M, Kweon MN, Sano Y, et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol. 2002;129:464-470.
40. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473-484.
41. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340:1697-1703.
42. Hill JC. Systemic cyclosporine in high-risk keratoplasty: long-term results. Eye. 1995;9:422-428.
43. Starzl TE. New approaches in the use of cyclosporine: with particular reference to the liver. Transplant Proc. 1988;20(suppl):356-360.
44. Feutren G. The optimal use of cyclosporin A in autoimmune diseases. J Autoimmun. 1992;5:183-195.
45. Lipman RM, Epstein RJ, Hendricks RL. Suppression of corneal neovascularization with cyclosporine. Arch Ophthalmol. 1992;110:405-407.
46. Dua HS, Jindal VK, Gomes JAP, et al. The effect of topical cyclosporin on conjunctiva-associated lymphoid tissue (CALT). Eye. 1996;10:433-438.
47. Bell TAG, Hunnisett AG. Cyclosporin A: tissue levels following topical and systemic administration to rabbits. Br J Ophthalmol. 1986;70:852-855.
48. Blanco G, Saornil MA, Domingo E, et al. Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Curr Eye Res. 2000;21:740-747.
49. James SE, Rowe A, Ilari L, et al. The potential for eye bank limbal rings to generate cultured corneal epithelial allografts. Cornea. 2001;20:488-494.
50. Ardjomand N, Berghold A, Reich ME. Loss of corneal Langerhans cells during storage in organ culture medium, Optisol and McCarey-Kaufman medium. Eye. 1998;12:134-138.
51. Kim HS, Sah WJ, Kim YJ, et al. Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation. Cornea. 2001;20:628-634.
52. Ti S, Anderson D, Touhami A, et al. Factors affecting outcome following transplantation of ex vivo expanded limbal epithelium on amniotic membrane for total limbal deficiency in rabbits. Invest Ophthalmol Vis Sci. 2002;43:2584-2592.
53. Barton K, Budenz DL, Khaw PT, et al. Glaucoma filtration surgery using amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42:1762-1768.
54. 2-microglobulin and enzymes by human amniotic epithelial cells. Nature. 1982;295:325-327.
55. Akle CA, Adinofi M, Welsh KI, et al. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981;2:1003-1005.
56. Hammer A, Hutter H, Blaschitz A, et al. Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol. 1997;37:161-171.
57. Meller D, Pires RTF, Mack RJS, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology. 2000;107:980-990.
58. Heiligenhaus A, Bauer D, Meller D, et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42:1969-1974.
59. Park WC, Tseng SCG. Modulation of acute and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci. 2000;41:2906-2914.
60. Shimmura S, Shimazaki J, Ohashi Y, et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408-413.
61. Hao Y, Ma DH, Hwang DG, et al. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19:348-352.
62. Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224-229.
63. Hanada K, Shimazaki J, Shimmura S, et al. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol. 2001;131:324-331.
64. Khokhar S, Sharma N, Kumar H, et al. Infection after use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface. Cornea. 2001;20:773-774.